1. Home
  2. OSUR vs TCI Comparison

OSUR vs TCI Comparison

Compare OSUR & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSUR
  • TCI
  • Stock Information
  • Founded
  • OSUR 2000
  • TCI 1983
  • Country
  • OSUR United States
  • TCI United States
  • Employees
  • OSUR N/A
  • TCI N/A
  • Industry
  • OSUR Medical/Dental Instruments
  • TCI Real Estate
  • Sector
  • OSUR Health Care
  • TCI Finance
  • Exchange
  • OSUR Nasdaq
  • TCI Nasdaq
  • Market Cap
  • OSUR 223.0M
  • TCI 239.1M
  • IPO Year
  • OSUR 1986
  • TCI N/A
  • Fundamental
  • Price
  • OSUR $2.81
  • TCI $37.70
  • Analyst Decision
  • OSUR Hold
  • TCI
  • Analyst Count
  • OSUR 1
  • TCI 0
  • Target Price
  • OSUR $3.00
  • TCI N/A
  • AVG Volume (30 Days)
  • OSUR 749.5K
  • TCI 3.7K
  • Earning Date
  • OSUR 05-07-2025
  • TCI 05-08-2025
  • Dividend Yield
  • OSUR N/A
  • TCI N/A
  • EPS Growth
  • OSUR N/A
  • TCI 59.61
  • EPS
  • OSUR N/A
  • TCI 0.92
  • Revenue
  • OSUR $161,626,000.00
  • TCI $47,452,000.00
  • Revenue This Year
  • OSUR N/A
  • TCI N/A
  • Revenue Next Year
  • OSUR $6.87
  • TCI N/A
  • P/E Ratio
  • OSUR N/A
  • TCI $42.84
  • Revenue Growth
  • OSUR N/A
  • TCI N/A
  • 52 Week Low
  • OSUR $2.36
  • TCI $25.50
  • 52 Week High
  • OSUR $4.98
  • TCI $40.15
  • Technical
  • Relative Strength Index (RSI)
  • OSUR 51.01
  • TCI 64.76
  • Support Level
  • OSUR $2.71
  • TCI $36.51
  • Resistance Level
  • OSUR $3.01
  • TCI $40.15
  • Average True Range (ATR)
  • OSUR 0.16
  • TCI 1.38
  • MACD
  • OSUR 0.05
  • TCI 0.36
  • Stochastic Oscillator
  • OSUR 68.46
  • TCI 66.48

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: